Portfolio company
Discuva
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Adjutecpharma
This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
Nabriva
This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.
C10 PHARMA
This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.
AdjutTec
This pharmaceutical company develops antibiotic resistance breakers to treat patients with multidrug-resistant bacterial and fungal infections.
Calixa Therapeutics
This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.
Abgentis
This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.
Omnix Medical
This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.
